BCAT1 and experimental autoimmune encephalomyelitis: To examine the systemic in vivo effect of BCAT1 inhibition, we adopted an experimental autoimmune encephalomyelitis (EAE) model widely utilized for studying the pathogenic responses of autoreactive Th17 cells33.